Zobrazeno 1 - 10
of 10
pro vyhledávání: '"A. D. Koltakova"'
Autor:
A. D. Koltakova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 112-117 (2023)
Checkpoint inhibitors (CPI) are anticancer drugs that activate the immune response against cancer cells. This type of treatment is highly effective, but also associates with many immunoinflammatory complications, including musculoskeletal. This revie
Externí odkaz:
https://doaj.org/article/5ae41e73226e4f3b90395de2644129fc
Autor:
A. D. Koltakova, A. M. Lila, O. G. Alekseeva, A. A. Fedenko, Y. V. Gridneva, A. S. Olshanskaya
Publikováno v:
Современная ревматология, Vol 16, Iss 5, Pp 46-52 (2022)
Objective: to describe musculoskeletal immune-mediated adverse events (iAEs) associated with the therapy of solid tumors with immune checkpoint inhibitors (ICIs, inhibitors of the PD-1/PD-L1 pathway).Patients and methods. 13 patients receiving ICIs t
Externí odkaz:
https://doaj.org/article/b651571d2d7d46de90e558bff186e959
Publikováno v:
Современная ревматология, Vol 17, Iss 1 (2023)
Objective: to describe the rheumatic aspects of arthralgia associated with aromatase inhibitor therapy in a clinical case series.Material and methods. The article presents a series of clinical cases – 16 patients (mean age 61±14 years) with histol
Externí odkaz:
https://doaj.org/article/26a3fd734f9f4275848bf71e84278161
Autor:
A. D. Koltakova
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 2, Pp 198-206 (2020)
The literature review considers the fundamental elements of a relationship between cancers and rheumatic diseases, including a variety of paraneoplastic syndromes, a profile of rheumatic diseases associated with the development of oncopathology, and
Externí odkaz:
https://doaj.org/article/e9877ccc56eb4a8ab5c4fa069bc85b40
Autor:
T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, A. D. Koltakova, E. E. Medved, S. S. Kudishina, A. V. Petrov, M. V. Sedunova, I. N. Pristavsky, E. A. Vasilenko, I. N. Bondareva, I. F. Umnova, P. A. Shesternya, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 4, Pp 407-414 (2019)
The paper presents the design, general characteristics of and possibilities of data usage from the All-Russian register of patients with psoriatic arthritis (PsA).The purpose of creating and introducing the register into Russian healthcare practice i
Externí odkaz:
https://doaj.org/article/59fb8f67acc440ed9dd0639dcd6322e4
Autor:
E. Yu. Loginova, Yu. L. Korsakova, A. D. Koltakova, E. E. Gubar, P. L. Karpova, S. I. Glukhova, T. V. Korotaeva
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 299-306 (2019)
Objective: to evaluate the clinical efficacy and safety of the targeted synthetic disease-modifying antirheumatic drug (DMARD) apremilast (AP; Otesla®) in patients with active psoriatic arthritis (PsA) at 14 and 26 weeks after starting the treatment
Externí odkaz:
https://doaj.org/article/5a7a05958e994f81ae605fb0e2d3e0cd
Autor:
A. D. Koltakova
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 2, Pp 210-217 (2019)
Observational cohort investigations are an effective way to study chronic diseases, including psoriatic arthritis, in clinical practice. One of the tools to support such research is registers that collect data related to various aspects of the diseas
Externí odkaz:
https://doaj.org/article/2d2a10f8321b464684dd024a3f728e66
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 6, Pp 739-745 (2019)
The current Treat-to-target (T2T) strategy in the management of patients with psoriatic arthritis (PsA) is based on strict control over the dynamics of a patient's status and timely correction of therapy according to the presence or absence of remiss
Externí odkaz:
https://doaj.org/article/f0a36c7981ef46c289a4069b0689ee09
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 6, Pp 610-615 (2018)
Achievement of minimal disease activity (MDA) is the main goal of the Treat-to-target (T2T) strategy in early psoriatic arthritis (ePsA). Radiographic progression in patients with ePsA treated according to the T2T strategy has been studied insufficie
Externí odkaz:
https://doaj.org/article/cafb3c7f13b84fd7b1215b8bdbc98b62
Autor:
Ekaterina A. Komech, Anastasia D. Koltakova, Anna A. Barinova, Anastasia A. Minervina, Maria A. Salnikova, Evgeniya I. Shmidt, Tatiana V. Korotaeva, Elena Y. Loginova, Shandor F. Erdes, Ekaterina A. Bogdanova, Mikhail Shugay, Sergey Lukyanov, Yury B. Lebedev, Ivan V. Zvyagin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Spondyloarthritis (SpA) comprises a number of inflammatory rheumatic diseases with overlapping clinical manifestations. Strong association with several HLA-I alleles and T cell infiltration into an inflamed joint suggest involvement of T cells in SpA
Externí odkaz:
https://doaj.org/article/4b94e9ba47754152bdbfddcb886412ef